Botulinum Antitoxin Heptavalent (2026)
key details
| Value | £1 |
|---|---|
| Status | active |
| Category (CPV) | 33600000 |
| Deadline | 13 Aug 2026 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-06be1b |
description
The provision of Botulinum Antitoxin Heptavalent
documents
- https://www.find-tender.service.gov.uk/Notice/066675-2026 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 26 Jun 2026 | Preliminary market engagement (UK2) | Procurement Act 2023 | 060298-2026 |
| 15 Jul 2026 | Tender notice (UK4) | Procurement Act 2023 | 066675-2026 |
more from Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
- Vitrocell Exposure System · £99,964 · 28 Jul 2026
- Card Payment Solution (2026 - 2029) · £105,000 · 23 Jul 2026
- Microbiological Safety Cabinet (Porton Down) · £12,488 · 23 Jul 2026
- NW Manchester Telepath LIMS annual support · £121,321 · 23 Jul 2026
- Porton Industrial Automated Control System Works · £1,950,000 · 22 Jul 2026
- Women in Leadership Training for AIA Directorate · 21 Jul 2026
- Provision for Membership to The Global Health Network (Global Health Protection · 20 Jul 2026
- Provision of Haematology Analysers for CDEP · 16 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.